All Locations

Top Companies in Switzerland

934 companies based in Switzerland, sorted by total funding raised.

Gravis Robotics

Gravis Robotics retrofits construction machines with its Gravis RACK hardware and touchscreen con...

Zurich, Switzerland51–200Construction Tech, Robotics
Series ATotal funding$223.0MAug 2026
CeQur

Insulin delivery patch device

Horw, Switzerland51–200Healthcare
Series ETotal funding$220.0MJun 2026
Sygnum

Sygnum is the world's first regulated digital asset bank, offering secure crypto services includi...

Barcelona, Switzerland201–500Fintech, Crypto & Web3
Growth EquityTotal funding$218.0MJan 2025
PharvarisIPO

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for ...

Zug, Switzerland51–200Biotech, Healthcare
Private EquityTotal funding$216.0MJun 2023
Ecorobotix

Ecorobotix develops AI-powered precision spraying technology that helps farmers reduce plant prot...

Yverdon-les-Bains, Switzerland201–500Artificial Intelligence, Climate Tech
Series DTotal funding$205.3MOct 2025
Polkadot

Polkadot is a multichain blockchain protocol enabling interoperability between independent blockc...

Zug, Switzerland51–200Crypto & Web3
Venture RoundTotal funding$193.1MJul 2020
GlycoEra

GlycoEra develops biologics that selectively degrade circulating autoantibodies, aiming to treat ...

Wädenswil, Switzerland11–50Biotech, Healthcare
Series BTotal funding$179.0MMay 2025
SWISSto12

Multi-orbit satellite antenna and payload manufacturer.

Renens, Switzerland51–200Space Tech
Series CTotal funding$173.2MJul 2026
21.co

21.co is the parent company of 21Shares and Amun, operating the world's largest suite of physical...

Zurich, Switzerland51–200Crypto & Web3, Fintech
Venture RoundTotal funding$171.0MSep 2022
Vaderis Therapeutics

Vaderis Therapeutics develops oral therapy designed to restore vascular balance through a targete...

Basel, Switzerland11–50Biotech, Healthcare
Series BTotal funding$171.0MAug 2026
Neurosterix

Neurosterix, founded in 2024, develops next-generation medicines that fine-tune brain signaling w...

Geneva, Switzerland11–50Biotech, Healthcare
Series BTotal funding$168.0MNov 2026
Numab

Numab designs and develops a new class of powerful therapeutics for the treatment of severe disea...

Horgen, Switzerland51–200Biotech, Drug Discovery
Extension RoundTotal funding$165.0MJan 2025
Addex TherapeuticsIPO

Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally ava...

Plan-les-Ouates, Switzerland11–50Biotech, Drug Discovery
Extension RoundTotal funding$155.9MAug 2022
BoardAcquired

Enterprise planning platform combining business intelligence, corporate performance management, a...

Chiasso, Switzerland201–500Business Intelligence, Data & Analytics
Series ATotal funding$153.8MJun 2026
ANYbotics

Developer of ANYmal autonomous legged robots for industrial inspection in hazardous environments,...

Zurich, Switzerland201–500Artificial Intelligence, Automation
Extension RoundTotal funding$152.5MSep 2025
Skycell

SkyCell develops hybrid containers, monitoring software, and connected hardware to protect pharma...

SwitzerlandHealthcare
Series DTotal funding$150.8MJun 2024
Quercis Pharma

Innovative medicines for orphan diseases

Zug, Switzerland1–10Biotech, Healthcare
Growth EquityTotal funding$150.0MDec 2021
VectivBioAcquired

GLP-2 analog apraglutide for short bowel syndrome

Basel, Switzerland11–50Biotech, Healthcare
Venture RoundTotal funding$145.0MJan 2023
BeekeeperAcquired

Beekeeper is a mobile-first frontline success platform connecting deskless workers with communica...

Zurich, Switzerland201–500SaaS
Growth EquityTotal funding$138.0MMar 2025
Anaveon

Anaveon develops next-generation biologics designed to selectively eliminate or reprogram pathoge...

Basel, Switzerland11–50Biotech, Healthcare
Series BTotal funding$137.3MDec 2021
Neural Concept

Neural Concept builds an engineering intelligence platform that speeds R&D cycles and improves pr...

Lausanne, Switzerland51–200Artificial Intelligence, SaaS
Growth EquityTotal funding$136.1MDec 2025
BeOne Medicines Ltd.IPO

BeOne Medicines, formerly BeiGene, is a global oncology company committed to advancing cancer car...

Basel, Switzerland5001–10000Biotech, Healthcare
Series ATotal funding$132.5MJan 2013
Asceneuron

Tau-targeting small molecules for neurodegeneration

Eysins, Switzerland11–50Biotech, Healthcare
Series CTotal funding$130.0MJul 2024
WISeKey International Holding LtdIPO

Global cybersecurity leader providing digital identity and IoT solutions using Blockchain, AI and...

Geneva, SwitzerlandCybersecurity
Venture RoundTotal funding$122.0MJan 2016
MindMaze

MindMaze Therapeutics develops digital therapy and monitoring products including MindMotion GO, M...

Lausanne, Switzerland51–200Artificial Intelligence, Healthcare
Venture RoundTotal funding$110.0MMay 2026